Jacques Lacroix

Quick and Simple Detection Technique to Assess the Binding of Antimicrotubule Agents to the Colchicine-Binding Site

Sébastien Fortin, Jacques Lacroix, Marie‐France Côté et al. · Biological Procedures Online · 2010 · 73 citations · Full text

Medicine, Oncology, Pharmacology +16

Antimitotic Antitumor Agents: Synthesis, Structure−Activity Relationships, and Biological Characterization of <i>N</i>-Aryl-<i>N</i>‘-(2-chloroethyl)ureas as New Selective Alkylating Agents

Emmanuelle Mounetou, Jean Legault, Jacques Lacroix et al. · Journal of Medicinal Chemistry · 2001 · 72 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin.

A. Lejeune, M. N. Moorjani, C Gicquaud et al. · PubMed · 1994 · 68 citations

Pharmacy, Pharmaceutics, Pharmacology +13

Design, Synthesis, Biological Evaluation, and Structure–Activity Relationships of Substituted Phenyl 4-(2-Oxoimidazolidin-1-yl)benzenesulfonates as New Tubulin Inhibitors Mimicking Combretastatin A-4

Sébastien Fortin, Lianhu Wei, Emmanuel Moreau et al. · Journal of Medicinal Chemistry · 2011 · 66 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.

Jean Legault, Jean-François Gaulin, Emmanuelle Mounetou et al. · PubMed · 2000 · 60 citations

Life Sciences, Biochemistry, Pharmacology +17